Cellipont Announces Plans For Commercial-Ready Cell Therapy Facility In Houston

Cellipont Bioservices, a leading cell therapy contract development and manufacturing services company, is planning a new commercial-ready site in The Woodlands, Texas.

Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), today announced plans for a 76,000 sq. ft. commercial-ready manufacturing facility for cell therapies and gene-modified cell therapies. Located in The Woodlands, Texas, the facility will include state-of-the-art manufacturing, process development, assay development and testing capabilities redundant with Cellipont’s 26,000 sq. ft. San Diego location. The new facility will be commissioned in phases, with the first phase scheduled to begin operation in the first half of 2023.

“Cellipont is excited to move forward with this next stage of our company’s development as a best-in-class cell therapy CDMO. As our client programs advance through the clinic and toward commercialization, we are working diligently to offer them state-of-the-art facilities and capabilities. This site near Houston is an ideal location to serve clients and patients across all of North America, with two major airports and a strong local workforce,” said Deborah Wild, Chief Executive Officer at Cellipont Bioservices.

Wild added, “Over the first half of this year, Cellipont has assembled a leadership team widely-recognized in the industry with extensive commercial experience. We are pleased to partner with established industry leaders on this expansion project, including building owner Vitrian, cell therapy design/build/qualification specialist cGMPnow and general contractor, LEAD Construction.”

“With this new expansion, we essentially have a blank canvas to create the ideal cell therapy facility in a phased approach as our clients grow their programs. We look forward to partnering with cGMPnow and LEAD Construction to make our vision reality,” said Mike O’Mara, Chief Operating Officer of Cellipont.

“We are proud that Cellipont Bioservices will call The Woodlands home. Their dynamic facility will be a jewel among the growing bioscience companies in our Research Forest commercial area. With healthcare as our largest business sector, Cellipont will undoubtedly enhance the sustainability of our medical hub,” said Gil Staley, Chief Executive Officer, The Woodlands Area Economic Development Partnership.

Ann Tanabe, CEO of industry group BioHouston, Inc. added, “We know that the Houston area is a great place for the life sciences industry to take root, so it’s wonderful when a company located in one of the premier biotech hubs – San Diego – recognizes this and chooses Houston as their next strategic location.”